These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 27677954)
1. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic. Yan SY; Fan JG; Qio L Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954 [TBL] [Abstract][Full Text] [Related]
2. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. Ringelhan M; O'Connor T; Protzer U; Heikenwalder M J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269 [TBL] [Abstract][Full Text] [Related]
5. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387 [TBL] [Abstract][Full Text] [Related]
7. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
8. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
9. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664 [TBL] [Abstract][Full Text] [Related]
10. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter]. Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711 [TBL] [Abstract][Full Text] [Related]
13. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Lin CL; Kao JH Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445 [TBL] [Abstract][Full Text] [Related]
15. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Iloeje UH; Yang HI; Chen CJ Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145 [TBL] [Abstract][Full Text] [Related]
16. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG; Mohammed R; Yuen MF; Kao JH J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903 [TBL] [Abstract][Full Text] [Related]
17. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma]. Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461 [TBL] [Abstract][Full Text] [Related]
18. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781 [TBL] [Abstract][Full Text] [Related]
19. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. Yu SJ; Kim YJ World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]